Follow Us

       


"Like" us on Facebook

Clinical Trials

Disease or Condition
Cancer - GE & Stomach Cancer
Title
GE & Stomach Cancer - MM-111-13-02-04/Merrimack
Description
Randomized, Open Label, Phase 2 Study of MM-111 and Paclitaxel with or without Trastuzumab in Patients with 'Traditional' and 'Non-Traditional' HER2 Expressing Carcinomas of the Distal Esophagus, Gastroesophageal (GE) Junction and Stomach Who Have Failed Front Line Metastatic or Locally Advanced Therapy
IRB Number
NCT01774851
Inclusion/Notes

For more information, please click here: http://www.clinicaltrials.gov/ct2/show/NCT01774851?term=NCT01774851&rank=1

Status
Open to Enrollment
Phone
(805) 898-2117

This is the fat footer - edit page 906 to add content.